AAAAAA

   
Results: 1-7 |
Results: 7
Oral versus combination mesalazine therapy in active ulcerative colitis: adouble-blind, double-dummy, randomized multicentre study
Authors: Vecchi, M Meucci, G Gionchetti, P Beltrami, M Di Maurizio, P Beretta, L Ganio, E Usai, P Campieri, M Fornaciari, G De Franchis, R
Citation: M. Vecchi et al., Oral versus combination mesalazine therapy in active ulcerative colitis: adouble-blind, double-dummy, randomized multicentre study, ALIM PHARM, 15(2), 2001, pp. 251-256
Reduced free protein S levels in patients with inflammatory bowel disease - Prevalence, clinical relevance, and role of anti-protein S antibodies
Authors: Saibeni, S Vecchi, M Valsecchi, C Faioni, EM Razzari, C De Franchis, R
Citation: S. Saibeni et al., Reduced free protein S levels in patients with inflammatory bowel disease - Prevalence, clinical relevance, and role of anti-protein S antibodies, DIG DIS SCI, 46(3), 2001, pp. 637-643
Quantification of intrahepatic hepatitis B virus (HBV) DNA in patients with chronic HBV infection
Authors: Cacciola, I Pollicino, T Squadrito, G Cerenzia, G Villari, D De Franchis, R Santantonio, T Brancatelli, S Colucci, G Raimondo, G
Citation: I. Cacciola et al., Quantification of intrahepatic hepatitis B virus (HBV) DNA in patients with chronic HBV infection, HEPATOLOGY, 31(2), 2000, pp. 507-512
Inflammatory bowel diseases are not associated with major hereditary conditions predisposing to thrombosis
Authors: Vecchi, M Sacchi, E Saibeni, S Meucci, G Tagliabue, L Duca, F De Franchis, R
Citation: M. Vecchi et al., Inflammatory bowel diseases are not associated with major hereditary conditions predisposing to thrombosis, DIG DIS SCI, 45(7), 2000, pp. 1465-1469
Chronic unexplained hypertransaminasemia may be caused by occult celiac disease
Authors: Bardella, MT Vecchi, M Conte, D Del Ninno, E Fraquelli, M Pacchetti, S Minola, E Landoni, M Cesana, BM De Franchis, R
Citation: Mt. Bardella et al., Chronic unexplained hypertransaminasemia may be caused by occult celiac disease, HEPATOLOGY, 29(3), 1999, pp. 654-657
A new mesalazine gel enema in the treatment of left-sided ulcerative colitis: a randomized controlled multicentre trial
Authors: Gionchetti, P Ardizzone, S Benvenuti, ME Porro, GB Biasco, G Cesari, P D'Albasio, G De Franchis, R Monteleone, G Pallone, F Ranzi, T Trallori, G Valpiani, D Vecchi, M Campieri, M
Citation: P. Gionchetti et al., A new mesalazine gel enema in the treatment of left-sided ulcerative colitis: a randomized controlled multicentre trial, ALIM PHARM, 13(3), 1999, pp. 381-388
Recognition of bactericidal/permeability-increasing protein by perinuclearanti-neutrophil cytoplasmic antibody-positive sera from ulcerative colitispatients: Prevalence and clinical significance
Authors: Vecchi, M Sinico, A Bianchi, MB Radice, A Gionchetti, P Campieri, M De Franchis, R
Citation: M. Vecchi et al., Recognition of bactericidal/permeability-increasing protein by perinuclearanti-neutrophil cytoplasmic antibody-positive sera from ulcerative colitispatients: Prevalence and clinical significance, SC J GASTR, 33(12), 1998, pp. 1284-1288
Risultati: 1-7 |